当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Cardiovascular disease: BET inhibitor attenuates heart failure
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-06-29 , DOI: 10.1038/nrd.2017.125 Megan Cully
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-06-29 , DOI: 10.1038/nrd.2017.125 Megan Cully
Heart failure (HF) is a leading cause of mortality and hospitalization. Writing in Science Translational Medicine, Duan and colleagues demonstrate that inhibition of bromodomain-containing protein 4 (BRD4), a member of the bromodomain and extraterminal domain (BET) family of epigenetic signalling proteins, reduces pathology and
中文翻译:
心血管疾病:BET抑制剂可减轻心力衰竭
心力衰竭(HF)是导致死亡和住院的主要原因。Duan及其同事在《科学转化医学》杂志上发表的文章证明,抑制含溴结构域蛋白4(BRD4)是表观遗传信号蛋白的溴结构域和末端外域(BET)家族的一员,可减少病理和
更新日期:2017-06-29
中文翻译:
心血管疾病:BET抑制剂可减轻心力衰竭
心力衰竭(HF)是导致死亡和住院的主要原因。Duan及其同事在《科学转化医学》杂志上发表的文章证明,抑制含溴结构域蛋白4(BRD4)是表观遗传信号蛋白的溴结构域和末端外域(BET)家族的一员,可减少病理和